Pearl River Capital, LLC Amicus Therapeutics, Inc. Transaction History

Pearl River Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.89 - $12.7 $51,230 - $65,786	-5,180 Reduced 19.82%	20,954 $255,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $12.75 $256,635 - $333,208	26,134 New	26,134 $273,000
Q3 2020 Nov 13, 2020	SELL	$12.89 - $15.89 $183,940 - $226,750	-14,270 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$8.86 - $15.69 $126,432 - $223,896	14,270 New	14,270 $215,000
Q1 2019 May 02, 2019	SELL	$10.04 - $13.92 $10,029 - $13,906	-999 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$8.38 - $13.44 $8,371 - $13,426	999 New	999 $10,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.